Delirium associated with a combination of sertraline, haloperidol, and benztropine.
Byerly
M J
MJ
Christensen
R C
RC
Evans
O L
OL
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D001590:Benztropine / Q000009:adverse effects*; D003693:Delirium / Q000139:chemically induced*; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline
D015057:1-Naphthylamine; D001590:Benztropine; D006220:Haloperidol; D008094:Lithium; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline